Amarin Corp Plc (AMRN)

[kvenne]

"At the time of the preliminary analysis, the evacetrapib group had mean HDL of 104 mg/dL vs. 46 mg/dL for the placebo group (mean difference, 130%), according to Nicholls.

Mean LDL levels were 55 mg/dL in the evacetrapib group and 84 mg/dL in the placebo group (mean difference, 37%), he said."

Ok so the way I read this is that there is no benefit to having your LDL below 100 or even further below 100 and also no benefit in raising your HDL.

So Kiwi and Ajax as far as I know where the ones saying injections treatments are the wave of the future and going to be the highest selling drug of all time. Hmmmmm.

Oh but wait lowering your LDL to new levels below 100 has no benefit. Going to be tough to get insurance to cover this large expense for the high cholesterol population. So like many of us said it is going to be restricted to the hyper cholesterol cases only.